Access to medicines

Access to medicines

One third of the world lacks  access to essential medicines.  In the poorest parts of Africa and Asia this figure rises to a half of the population. We challenge the high cost of medicines and the absence of treatment for many of the diseases affecting ou

Too often  we cannot treat patients because the medicines are too expensive, or they are no longer produced.  Sometimes, the only drugs we have are highly toxic or ineffective and nobody is looking for a better cure. 
As a medical humanitarian organisation, it is fundamentally unacceptable that access to essential medicines is increasingly difficult, particularly for the most common global infectious diseases. 

 
MSF treats nearly 20,000 sexual violence survivors in five years, and this is only the tip of the iceberg
Sexual and Gender Based Violence

MSF treats nearly 20,000 sexual violence survivors in five years, and this is only the tip of the iceberg

Article 25 Oct 2023
 
One Year Later: Logistics lessons from the world's first Hepatitis E campaign in South Sudan
South Sudan

One Year Later: Logistics lessons from the world's first Hepatitis E campaign in South Sudan

Article 20 Oct 2023
 
Khartoum: Lack of essential visas for MSF staff threatens life-saving care in hospital
Access to medicines

Khartoum: Lack of essential visas for MSF staff threatens life-saving care in hospital

Press Release 9 Aug 2023
 
MSF calls again on J&J to withdraw or abandon extended patents on lifesaving TB drug as main patent expires in India today, opening door to more affordable generics
Access to medicines

MSF calls again on J&J to withdraw or abandon extended patents on lifesaving TB drug as main patent expires in India today, opening door to more affordable generics

Press Release 18 Jul 2023
 
MSF calls on Gavi to step up efforts to improve vaccine access for children up to at least five years old
Access to medicines

MSF calls on Gavi to step up efforts to improve vaccine access for children up to at least five years old

Statement 12 Jun 2023
 
MSF demands J&J give up its patent monopoly on TB drug to put lives over profits
Access to medicines

MSF demands J&J give up its patent monopoly on TB drug to put lives over profits

Press Release 26 Apr 2023